ADMA Biologics Stock (NASDAQ: ADMA) stock price, news, charts, stock research, profile.
Open | $6.900 |
Close | $6.910 |
Volume / Avg. | 2.413M / 2.512M |
Day Range | 6.760 - 6.940 |
52 Wk Range | 3.060 - 6.810 |
Market Cap | $1.616B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 0 |
Short Interest | 3.24% |
Days to Cover | 2.59 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ADMA Biologics (NASDAQ: ADMA) through any online brokerage.
Other companies in ADMA Biologics’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), Day One Biopharmaceutical (NASDAQ:DAWN), Fusion Pharmaceuticals (NASDAQ:FUSN), Xencor (NASDAQ:XNCR) and Protagonist Therapeutics (NASDAQ:PTGX).
The latest price target for ADMA Biologics (NASDAQ: ADMA) was reported by HC Wainwright & Co. on Tuesday, March 26, 2024. The analyst firm set a price target for 7.50 expecting ADMA to rise to within 12 months (a possible 7.54% upside). 11 analyst firms have reported ratings in the last year.
The stock price for ADMA Biologics (NASDAQ: ADMA) is $6.974 last updated Today at May 6, 2024 at 6:12 PM EDT.
There are no upcoming dividends for ADMA Biologics.
ADMA Biologics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for ADMA Biologics.
ADMA Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.